New York A 9651: Establishes a maternal health monitoring pilot program

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A09651 Summary:

BILL NOA09651 

&nbsp

SAME ASSAME AS S09084

&nbsp

SPONSORSolages

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

Add §2500-n, Pub Health L

&nbsp

Establishes a maternal health monitoring pilot program within the department of health to offer eligible participants improved maternal health care through remote patient monitoring for maternal hypertension and maternal diabetes; requires delivery of a report.

Go to top A09651 Actions:

BILL NOA09651 

&nbsp

01/21/2026referred to health

Go to topA09651 Committee&nbspVotes:

Go to topA09651 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA09651 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 9651

 IN ASSEMBLY

 January 21, 2026
 ___________

 Introduced by M. of A. SOLAGES -- read once and referred to the Commit-
 tee on Health

 AN ACT to amend the public health law, in relation to establishing a
 maternal health monitoring pilot program

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. The public health law is amended by adding a new section
 2 2500-n to read as follows:
 3 § 2500-n. Maternal health monitoring pilot program. 1. As used in this
 4 section:
 5 (a) "Eligible participant" means a patient who meets all of the
 6 following criteria:
 7 (i) the patient is a recipient of medical assistance;
 8 (ii) the patient is a member of a participating managed care organiza-
 9 tion; and
 10 (iii) the patient is pregnant.
 11 (b) "Escalation pathway" means an agreement between the participating
 12 managed care organizations and the technology vendor on a process to
 13 follow when an eligible participant's measurements are concerning and
 14 warrant further review and investigation.
 15 (c) "Health care provider" means an obstetrician or maternal fetal
 16 medicine physician who meet all of the following criteria:
 17 (i) such person is licensed in the state of New York;
 18 (ii) such person is an in-network provider for the participating
 19 managed care organizations; and
 20 (iii) such person provides care for an eligible participant during
 21 pregnancy.
 22 (d) "Participating managed care organization" means a managed care
 23 organization selected by the department to administer the pilot program.
 24 (e) "Pilot program" means the maternal health monitoring pilot program
 25 established by this section.
 26 (f) "Remote monitoring clinical care team" means a group made up of
 27 nurses licensed to practice in New York state, dietitians, and certified
 28 diabetes education specialists who are monitoring eligible participants'

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD14280-01-5

 A. 9651 2

 1 measurements, and providing nutrition guidance, diabetes and hyperten-
 2 sion condition management counseling, and pregnancy and postpartum
 3 advice.
 4 (g) "Remote patient monitoring for maternal hypertension and maternal
 5 diabetes" means technology provided by the technology vendor that:
 6 (i) collects health data from an eligible participant and electron-
 7 ically transmits that information securely for interpretation and recom-
 8 mendation;
 9 (ii) uses devices that are authorized by the U.S. Food and Drug Admin-
 10 istration;
 11 (iii) monitors health data, including blood pressure, weight, blood
 12 glucose levels, or other physiological health data as determined by the
 13 eligible participant's health care provider;
 14 (iv) transmits health data through cellular networks; and
 15 (v) provides preprogrammed equipment specifically for each eligible
 16 participant.
 17 (h) "Technology vendor" means a technology company selected by the
 18 department to contract with the participating managed care organizations
 19 in administering the pilot program.
 20 2. (a) A maternal health monitoring pilot program is hereby estab-
 21 lished within the department to offer eligible participants improved
 22 maternal health care through remote patient monitoring for maternal
 23 hypertension and maternal diabetes. The department shall select one or
 24 more participating managed care organizations and one technology vendor
 25 to administer the pilot program in a manner to be d